Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (271-280 of 339) with videos related to

Pageof 34
Sort By:
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
European Journal of Endocrinology|June 23, 2020
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort studyFatemeh Majidi, Samuela Martino, Mustafa Kondakci, et al.
Leukemia|September 6, 2023
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDSKarin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study groupJan Krönke, Richard F Schlenk, Kai-Ole Jensen, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
European Journal of Haematology|September 6, 2015
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemiaBlanca Xicoy, Ulrich Germing, María-José Jimenez, et al.
Blood Advances|August 13, 2021
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDSHoward S Oster, Simon Crouch, Alexandra Smith, et al.
Pageof 34

Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
European Journal of Endocrinology|June 23, 2020
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort studyFatemeh Majidi, Samuela Martino, Mustafa Kondakci, et al.
Leukemia|September 6, 2023
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDSKarin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study groupJan Krönke, Richard F Schlenk, Kai-Ole Jensen, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
European Journal of Haematology|September 6, 2015
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemiaBlanca Xicoy, Ulrich Germing, María-José Jimenez, et al.
Blood Advances|August 13, 2021
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDSHoward S Oster, Simon Crouch, Alexandra Smith, et al.
Pageof 34